An official website of the United States government
NIH Guide: Weekly Index for November 12, 2021
Weekly NIH Guide Notices
November 12, 2021
General Notices
-
Notice of Informational Webinar on the NIGMS PREP Program PAR-20-066, "Postbaccalaureate Research Education Program (R25)"
(NOT-GM-22-007)National Institute of General Medical Sciences
-
Notice of Informational Webinar on the NIGMS IMSD and G-RISE Research Training Programs
(NOT-GM-22-008)National Institute of General Medical Sciences
-
Notice of Availability of Pre-Application Webinar Recording and FAQ for RFA-MH-22-100 Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries
(NOT-MH-22-065)National Institute of Mental Health
-
Notice of Pre-Application Webinar for RFA-MH-22-120, "Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)"
(NOT-MH-22-070)National Institute of Mental Health
-
Notice of Pre-Application Webinar for Cellular Senescence Network (SenNet) RFAs: RFA-RM-22-003, RFA-RM-22-004, RFA-RM-22-005
(NOT-RM-22-004)Office of Strategic Coordination (Common Fund)
-
Request for Information: Seeking Input from Cohort and Biorepository Researchers on Liquid Biopsy Studies for Early Cancer Detection
(NOT-CA-22-010)National Cancer Institute
-
Request for Information: Seeking Input from Technology Developers on Liquid Biopsy Studies for Early Cancer Detection
(NOT-CA-22-011)National Cancer Institute
-
Request for Information (RFI) on the NINR 2022-2026 Strategic Plan Framework
(NOT-NR-22-001)National Institute of Nursing Research
Notice of Changes to Funding Opportunities
-
Notice of Correction to PAR-21-035, Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trials Required)".
(NOT-CA-22-012)National Cancer Institute
-
Notice of Early Expiration of NOT-HL-20-755 "Notice of Special Interest (NOSI): Heart, lung, blood and sleep focused ancillary studies to large ongoing clinical studies"
(NOT-HL-21-035)National Heart, Lung, and Blood Institute
-
Notice of Change to Application Due Dates for PAR-21-281, "Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Clinical Trials Not Allowed)"
(NOT-OD-22-020)NIH Basic Behavioral and Social Science Opportunity Network
-
Notice of Change to Review Dates of PAR-22-054, Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
(NOT-RM-22-003)Office of Strategic Coordination (Common Fund)
-
Notice of Change to Receipt Date for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-336 (K12), PAR-21-340 (RC2), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32)
(NOT-TR-22-007)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Change to Expansion of Eligibility of Optional Companion Applications for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-340 (RC2), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32)
(NOT-TR-22-008)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Change to PI effort and eligibility of foreign components for PAR-21-336: Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
(NOT-TR-22-009)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R01 Clinical Trial Optional)
(NOT-MH-22-020)National Institute of Mental HealthOffice of Research on Women's Health
-
RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R21 Clinical Trial Optional)
(NOT-MH-22-021)National Institute of Mental HealthOffice of Research on Women's Health
-
RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R34 Clinical Trial Optional)
(NOT-MH-22-022)National Institute of Mental HealthOffice of Research on Women's Health
Notices of Special Interest
-
Notice of Special Interest: Administrative Supplements for Summer Research Experiences for Students and Science Teachers
(NOT-ES-22-001)National Institute of Environmental Health SciencesOffice of Research on Women's Health
-
Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised)
(NOT-HL-21-030)National Heart, Lung, and Blood Institute
-
Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
(NOT-NS-22-017)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Eye Institute
Funding Opportunities
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
(PAR-21-353)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): November 5, 2024
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
(PAR-21-354)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): November 16, 2024
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
(PAR-21-355)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): November 16, 2024
-
Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
(PAR-22-028)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): December 17, 2024
-
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
(PAR-22-030)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): October 10, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster